Showing results (2041-2050 of 2,092) with videos related to

Sort By:
Pageof 210
Journal of Affective Disorders|July 28, 2021
Sex differences in zonulin in affective disorders and associations with current mood symptomsA Maget, N Dalkner, C Hamm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal CancerMarika Ciprotti, Niall C Tebbutt, Fook-Thean Lee, et al.
Cancer Cell|November 28, 2021
Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancerLauren C Shapiro, Astha Thakkar, Sean T Campbell, et al.
Molecular Genetics and Metabolism|March 2, 2010
Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders ConsortiumJennifer Seminara, Mendel Tuchman, Lauren Krivitzky, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2016
Neural correlates of the LSD experience revealed by multimodal neuroimagingRobin L Carhart-Harris, Suresh Muthukumaraswamy, Leor Roseman, et al.
The Journal of Biological Chemistry|April 1, 2015
LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2Hannah Nguyen, Abdellah Allali-Hassani, Stephen Antonysamy, et al.
Blood|September 24, 2024
A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohortMendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, et al.
The New England Journal of Medicine|September 2, 2022
Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant TuberculosisFrancesca Conradie, Tatevik R Bagdasaryan, Sergey Borisov, et al.
The Journal of Clinical Investigation|February 20, 2024
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependencySarah Aminov, Orsi Giricz, David T Melnekoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2015
A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung CancerTaofeek K Owonikoko, Suresh S Ramalingam, Daniel L Miller, et al.
Pageof 210